Cadrenal Therapeutics, Inc. (CVKD) has 9 open-market insider trades by 3 insiders since 2023. The most active filer is Quang X. Pham, CEO & Chairman +1.
| Name | Title | Tier | Trades | Value | Last Trade |
|---|---|---|---|---|---|
| Quang X. Pham | CEOChairman10% Owner | — | 4 | $302K | 2026-06-29 |
| John Raymond Murphy | Dir | — | 3 | $61K | 2023-10-05 |
| Matthew K. Szot | CFO | — | 2 | $49K | 2025-12-29 |
| Insider | Title | Type | Value | Date |
|---|---|---|---|---|
| Quang X. Pham | CEO & Chairman +1 | Sell | $22K | 2026-06-29 |
| Quang X. Pham | CEO & Chairman +2 | Sell | $34K | 2026-06-25 |
| Quang X. Pham | CEO & Chairman +2 | Sell | $40K | 2026-06-22 |
| Quang X. Pham | CEO & Chairman +2 | Sell | $13K | 2026-06-16 |
| Quang X. Pham | CEO & Chairman +2 | Sell | $70K | 2026-06-11 |
| Quang X. Pham | CEO & Chairman +2 | Sell | $93K |
Companies that share insiders with CVKD, and sector peers with recent insider buying. Related by who files, not by how the stocks move.
| 2026-06-08 |
| Quang X. Pham | CEO & Chairman +1 | Sell | $36K | 2026-06-03 |
| Quang X. Pham | CEO & Chairman +1 | Sell | $3K | 2026-05-29 |
| Quang X. Pham | CEO & Chairman +1 | Sell | $7K | 2026-05-22 |
| Quang X. Pham | CEO & Chairman +1 | Sell | $69K | 2026-05-11 |
| Matthew K. Szot | CFO | Sell | $138K | 2025-12-29 |
| Quang X. Pham | Chairman & 10% | Sell | $34K | 2025-10-24 |
| Matthew K. Szot | CFO | Sell | $50K | 2025-10-24 |
| Matthew K. Szot | CFO | Sell | $49K | 2025-10-09 |
| Quang X. Pham | Chairman & 10% | Sell | $51K | 2025-10-09 |